Naama Courtemanche

Naama Courtemanche has a strong background in program management, quality assurance, and operations within the biotechnology and life sciences industry. Naama's expertise in regulatory CMC strategy, product development, manufacturing, and project management has been showcased in various roles at companies such as Cingulate Therapeutics, Genzyme, and Dexcom. Naama's academic background includes a Master of Business Administration from the University of Michigan and a Bachelor's Degree in Biology from Tel Aviv University.